(a) The Illinois Comprehensive Health Insurance Board shall study a catastrophic pharmaceutical assistance coverage option. The Board may contract with a private entity for the completion of all or part of the study. Specifically, the study shall:
- (1) Assess the need for a catastrophic pharmaceutical assistance coverage option, including information on the number of individuals in need of such a benefit.
- (2) Estimate the cost of providing a catastrophic pharmaceutical assistance coverage option through the Illinois Comprehensive Health Insurance Plan or another public or private entity.
- (3) Recommend ways to create a catastrophic pharmaceutical assistance coverage option.
- (b) The Board may accept donations, in trust, from any legal source, public or private, for deposit into a specially created trust account and for expenditure, without the necessity of being appropriated, solely for the purpose of conducting all or part of the study.
- (c) The Board may enter into intergovernmental agreements with other State agencies for the purpose of conducting all or part of the study.
- (d) The Board shall issue a report with recommendations to the Governor and the General Assembly by January 1, 2003.
(Source: P.A. 92-594, eff. 6-27-02.)